Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells

T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated by myeloid dendritic cells (myDC) that initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tijtgat, Jens, De Munck, Jolien, Dufait, Inès, Schwarze, Julia Katharina, Van Riet, Ivan, Franceschini, Lorenzo, Breckpot, Karine, Aerts, Joeri L., Neyns, Bart, Tuyaerts, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581672/
https://www.ncbi.nlm.nih.gov/pubmed/34777344
http://dx.doi.org/10.3389/fimmu.2021.733506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581672/
https://www.ncbi.nlm.nih.gov/pubmed/34777344
http://dx.doi.org/10.3389/fimmu.2021.733506

Ejemplares similares